Inverness Counsel’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $247K | Buy |
2,593
+100
| +4% | +$9.9K | 0.01% | 168 |
|
|
2022
Q2 | $231K | Hold |
2,493
| – | – | 0.01% | 155 |
|
|
2022
Q1 | $252K | Sell |
2,493
-30
| -1% | -$3.15K | 0.01% | 168 |
|
|
2021
Q4 | $260K | Sell |
2,523
-150
| -6% | -$13.9K | 0.01% | 171 |
|
|
2021
Q3 | $227K | Sell |
2,673
-300
| -10% | -$25.1K | 0.01% | 167 |
|
|
2021
Q2 | $248K | Sell |
2,973
-53
| -2% | -$4.34K | 0.01% | 155 |
|
|
2021
Q1 | $228K | Buy |
3,026
+33
| +1% | +$2.4K | 0.01% | 140 |
|
|
2020
Q4 | $204K | Buy |
+2,993
| New | +$195K | 0.01% | 140 |
|
|
2020
Q2 | – | Sell |
-3,550
| Closed | -$211K | – | 128 |
|
|
2020
Q1 | $211K | Sell |
3,550
-545
| -13% | -$36.4K | 0.01% | 110 |
|
|
2019
Q4 | $304K | Sell |
4,095
-64
| -2% | -$4.49K | 0.01% | 103 |
|
|
2019
Q3 | $262K | Buy |
+4,159
| New | +$246K | 0.01% | 101 |
|
|
2019
Q2 | – | Sell |
-3,713
| Closed | -$200K | – | 120 |
|
|
2019
Q1 | $200K | Sell |
3,713
-9,745
| -72% | -$601K | 0.01% | 112 |
|
|
2018
Q4 | $882K | Buy |
13,458
+6,698
| +99% | +$500K | 0.06% | 76 |
|
|
2018
Q3 | $532K | Sell |
6,760
-2,380
| -26% | -$170K | 0.03% | 92 |
|
|
2018
Q2 | $588K | Sell |
9,140
-2,410
| -21% | -$159K | 0.03% | 90 |
|
|
2018
Q1 | $719K | Sell |
11,550
-259,685
| -96% | -$18.6M | 0.04% | 93 |
|
|
2017
Q4 | $19.7M | Buy |
271,235
+8,040
| +3% | +$585K | 1.23% | 33 |
|
|
2017
Q3 | $21.4M | Buy |
263,195
+190,620
| +263% | +$15.1M | 1.51% | 30 |
|
|
2017
Q2 | $5.84M | Buy |
72,575
+61,285
| +543% | +$4.84M | 0.41% | 50 |
|
|
2017
Q1 | $880K | Sell |
11,290
-770
| -6% | -$61.5K | 0.06% | 72 |
|
|
2016
Q4 | $940K | Sell |
12,060
-112,572
| -90% | -$9.11M | 0.07% | 70 |
|
|
2016
Q3 | $11.1M | Sell |
124,632
-208,489
| -63% | -$19.7M | 0.87% | 36 |
|
|
2016
Q2 | $31.9M | Sell |
333,121
-5,945
| -2% | -$592K | 2.48% | 10 |
|
|
2016
Q1 | $35.2M | Buy |
339,066
+36,197
| +12% | +$3.52M | 2.73% | 9 |
|
|
2015
Q4 | $29.6M | Buy |
302,869
+19,370
| +7% | +$1.9M | 2.24% | 16 |
|
|
2015
Q3 | $27.4M | Buy |
283,499
+4,435
| +2% | +$466K | 2.31% | 13 |
|
|
2015
Q2 | $29.3M | Buy |
279,064
+46,932
| +20% | +$4.8M | 2.12% | 12 |
|
|
2015
Q1 | $24M | Buy |
232,132
+12,033
| +5% | +$1.22M | 1.76% | 20 |
|
|
2014
Q4 | $21.2M | Buy |
220,099
+21,414
| +11% | +$1.89M | 1.63% | 24 |
|
|
2014
Q3 | $15.8M | Buy |
198,685
+6,393
| +3% | +$504K | 1.27% | 32 |
|
|
2014
Q2 | $14.5M | Sell |
192,292
-99,290
| -34% | -$7.5M | 1.13% | 33 |
|
|
2014
Q1 | $21.8M | Sell |
291,582
-16,861
| -5% | -$1.19M | 1.74% | 23 |
|
|
2013
Q4 | $22.1M | Sell |
308,443
-6,090
| -2% | -$391K | 1.75% | 17 |
|
|
2013
Q3 | $17.9M | Buy |
314,533
+28,840
| +10% | +$1.72M | 1.53% | 25 |
|
|
2013
Q2 | $16.3M | Buy |
+285,693
| New | +$16.6M | 1.46% | 25 |
|
Other funds holding CVS
Inverness Counsel's CVS Position: Q3 2022 in Review
Inverness Counsel increased its CVS Health (CVS) stake by 4% in Q3 2022, buying an estimated $9.9K and bringing the position to 2,593 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #168.
Inverness Counsel first reported a position in CVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $35.2M in Q1 2016. 2,326 funds tracked by Wall St. Rank hold CVS as of Q3 2022.
- Inverness Counsel held 2,593 shares of CVS Health worth $247K as of Q3 2022.
- Inverness Counsel bought 100 CVS Health shares in Q3 2022, an estimated $9.9K.
- CVS Health made up 0.01% of Inverness Counsel's portfolio in Q3 2022, its #168 holding.
- Inverness Counsel first reported a position in CVS Health in Q2 2013 and has held it in 35 quarters since.
- Inverness Counsel's CVS Health position peaked at $35.2M in Q1 2016.
- 2,326 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.
Based on Inverness Counsel's 13F filing for Q3 2022, filed 26 Oct 2022.